Why Quintiles Transnational Holdings (Q) Is Down Today

NEW YORK (TheStreet) -- Quintiles Transnational Holdings  (Q) dipped 2.42% to $51.54 at 10:28 a.m. on Thursday after the company, the world's largest provider of biopharmaceutical development and commercial outsourcing services, priced the secondary public offering by some of its shareholders.

The shareholders will sell 15 million shares at $52 a share. The offering, which should close March 18, includes a 30-day option to purchase up to an additional 2.25 million shares.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Q Chart

Q data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

SBA Communications, Quintiles IMS Holdings to Be Added to S&P 500

Parexel Is Discovering the Drugs of the Future

Analysts' Actions -- Arista, Capital One, Avis, Workday and More

Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More